Miyagi, Japan

Kuniyuki Kano

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kuniyuki Kano: Innovator in Pulmonary Hypertension Treatment

Introduction

Kuniyuki Kano is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary hypertension. His innovative work has led to the development of novel therapeutic agents that aim to improve patient outcomes.

Latest Patents

Kuniyuki Kano holds 2 patents related to pulmonary hypertension. His latest patents include a prophylactic or therapeutic agent for pulmonary hypertension comprising an unsaturated 5-membered heterocycle-containing compound. This invention provides a preventive or therapeutic agent that includes a specific compound represented by a defined formula. Additionally, he has developed a pulmonary hypertension preventative or therapeutic agent containing emetine or a salt thereof, which addresses the need for new therapeutic options in this area.

Career Highlights

Kano is affiliated with Tohoku University, where he conducts research and develops innovative solutions for medical challenges. His work is characterized by a commitment to advancing therapeutic strategies for complex health issues.

Collaborations

Throughout his career, Kuniyuki Kano has collaborated with esteemed colleagues, including Hiroaki Shimokawa and Jyunken Aoki. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments.

Conclusion

Kuniyuki Kano's contributions to the field of pulmonary hypertension treatment exemplify the impact of innovative research in medicine. His patents and collaborations reflect a dedication to improving health outcomes for patients suffering from this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…